Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar;98(1):57-105.
doi: 10.1111/1468-0009.12436. Epub 2019 Dec 4.

The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review

Amanda I Mauri  1   2 , Tarlise N Townsend  1   2   3 , Rebecca L Haffajee  1   2   4
Affiliations

The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review

Amanda I Mauri et al. Milbank Q. 2020 Mar.

Abstract

Policy Points This scoping review reveals a growing literature on the effects of certain state opioid misuse prevention policies, but persistent gaps in evidence on other prevalent state policies remain. Policymakers interested in reducing the volume and dosage of opioids prescribed and dispensed can consider adopting robust prescription drug monitoring programs with mandatory access provisions and drug supply management policies, such as prior authorization policies for high-risk prescription opioids. Further research should concentrate on potential unintended consequences of opioid misuse prevention policies, differential policy effects across populations, interventions that have not received sufficient evaluation (eg, Good Samaritan laws, naloxone access laws), and patient-related outcomes.

Context: In the midst of an opioid crisis in the United States, an influx of state opioid misuse prevention policies has provided new opportunities to generate evidence of policy effectiveness that can inform policy decisions. We conducted a scoping review to synthesize the available evidence on the effectiveness of US state interventions to improve patient and provider outcomes related to opioid misuse and addiction.

Methods: We searched six online databases to identify evaluations of state opioid policies. Eligible studies examined legislative and administrative policy interventions that evaluated (a) prescribing and dispensing, (b) patient behavior, or (c) patient health.

Findings: Seventy-one articles met our inclusion criteria, including 41 studies published between 2016 and 2018. These articles evaluated nine types of state policies targeting opioid misuse. While prescription drug monitoring programs (PDMPs) have received considerable attention in the literature, far fewer studies addressed other types of state policy. Overall, evidence quality is very low for the majority of policies due to a small number of evaluations. Of interventions that have been the subject of considerable research, promising means of reducing the volume and dosages of opioids prescribed and dispensed include drug supply management policies and robust PDMPs. Due to low study number and quality, evidence is insufficient to draw conclusions regarding interventions targeting patient behavior and health outcomes, including naloxone access laws and Good Samaritan laws.

Conclusions: Recent research has improved the evidence base on several state interventions targeting opioid misuse. Specifically, moderate evidence suggests that drug supply management policies and robust PDMPs reduce opioid prescribing. Despite the increase in rigorous evaluations, evidence remains limited for the majority of policies, particularly those targeting patient health-related outcomes.

Keywords: Opioid; drug overdose; scoping review; state policy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Literature Search and Selection Process
See this image and copyright information in PMC

References

    1. Hedegaard H, Miniño A, Warner M. Drug Overdose Deaths in the United States, 1999‐2017. Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention; 2018. - PubMed
    1. Scholl L. Drug and opioid‐involved overdose deaths—United States, 2013‐2017. MMWR Morb Mortal Wkly Rep. 2019;67 10.15585/mmwr.mm6751521e1. - DOI - PMC - PubMed
    1. Hedegaard H. Drug Overdose Deaths in the United States, 1999‐2016. Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention; 2017:8. - PubMed
    1. Cerdá M, Santaella J, Marshall BDL, Kim JH, Martins SS. Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: a national study. J Pediatr. 2015;167(3):605‐612.e2. 10.1016/j.jpeds.2015.04.071. - DOI - PMC - PubMed
    1. Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36(1):559‐574. 10.1146/annurev-publhealth-031914-122957. - DOI - PubMed

Publication types